Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Vs Preemptive Oral Valganciclovir for Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients: A Clinical and Pharmacoeconomic Study

NCT00374686 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00374686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00374686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Vs Preemptive Oral Valganciclovir for Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients: A Clinical and Pharmacoeconomic Study
Lead sponsor
Washington University School of Medicine
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2003
Completion date
September 30, 2005
Enrollment
120
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infection